(Q39349217)

11 September 2017

Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer (English)

1 reference

11 September 2017

1 reference

K Ahlqvist

1

1 reference

11 September 2017

K Saamarthy

2

1 reference

11 September 2017

A S Syed Khaja

3

1 reference

11 September 2017

A Bjartell

4

1 reference

11 September 2017

R Massoumi

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

14 May 2012

1 reference

11 September 2017

1 reference

11 September 2017

32

1 reference

11 September 2017

12

1 reference

11 September 2017

1601-1608

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.175

11 September 2017

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

The PCa Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Interleukin-6: a candidate mediator of human prostate cancer morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Bcl3-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Expression of the Bcl-3 proto-oncogene suppresses p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

ID2 promotes the expansion and survival of growth-arrested pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Transcriptional regulator Id2 controls survival of hepatic NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Inhibitor of differentiation 1 promotes endothelial survival in a bleomycin model of lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Inactivation of ID-1 gene induces sensitivity of prostate cancer cells to chemotherapeutic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Evidence of a novel antiapoptotic factor: role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.175

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.175

1 reference

Dimensions Publication ID

11 September 2017

0 references

1 reference